SequelSEC

Bespoke Extracts, Inc. BSPK

Pharmaceutical Preparations · CIK 0001409197 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.42M
Fiscal year ended 2025-09-30
Operating income
-$640.30K
Fiscal year ended 2025-09-30
Free cash flow
Unavailable
Fiscal year ended 2025-09-30

Valuation, from the filing

Public float$760.00KMarket value of stock held by non-affiliates, as stated on the cover page for 2024-06-30
Float per share$0.07Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2024-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.15x6th
CapEx / revenue53.7%91th
Gross margin40.5%23th
Revenue YoY growth42.3%72th
Operating margin-89.0%61th
Net margin-92.8%55th
SBC / revenue17.7%47th
FCF margin-79.6%50th

Bespoke Extracts, Inc. (BSPK) reported revenue of $1.42M and net income of -$730.56K for the fiscal year ended 2025-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Bespoke Extracts, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Bespoke Extracts, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Revenue$1.42M
Cost of revenue$751.35K
Gross profit$671.70K
Operating income-$640.30K
Net income-$730.56K
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$730.56K
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$1.16M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Bespoke Extracts, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Cash & equivalentsUnavailable
Total assets$295.57K
Current assets$196.83K
Total liabilities$2.89M
Current liabilities$1.87M
Total equity incl. NCI-$2.60M
Temporary (mezzanine) equityUnavailable
Inventory$63.66K
Accounts receivable$103.53K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Bespoke Extracts, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Operating cash flow-$259.70K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$255.00K
Net change in cashUnavailable
Stock-based compensation-$13.68K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Bespoke Extracts, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Free cash flowUnavailable
Gross margin47.2%
Operating margin-45.0%
FCF marginUnavailable
SBC / revenue-1.0%
Current ratio0.11x
Revenue YoY growth31.8%
Net margin-51.3%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BSPK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-27View SEC filing
10-Q · Filed 2025-06-30View SEC filing
10-K · Filed 2025-04-21View SEC filing
10-Q · Filed 2024-11-13View SEC filing
10-Q · Filed 2024-10-08View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.